Reapplix
is a Denmark-based biotechnology company that develops and commercializes novel therapeutics for the treatment of diabetic foot ulcers... Read moreReapplix
is a Denmark-based biotechnology company that develops and commercializes novel therapeutics for the treatment of diabetic foot ulcers... Read more
News
Apr 06, 2026
PRWeb
Press Release: Reapplix : Reapplix Awarded Technology Breakthrough Designation with Premier Inc. for Its 3C Patch Wound Management System
Jul 29, 2025
Reapplix Vimeo Channel
Reapplix posted a video "Clinical Corner- March 2025 Mendivil Article" on VIMEO
Jul 20, 2023
Benzinga
Reapplix: Reapplix wins 2023 Frost & Sullivan's Best Practices Technology Innovation Leadership Award
Nov 07, 2022
Reapplix Vimeo Channel
Reapplix posted a video "How to prepare and apply 3C Patch on wounds" on VIMEO
Oct 27, 2022
Reapplix Vimeo Channel
Reapplix posted a video "Gunnel" on VIMEO
Sep 28, 2022
Reapplix Vimeo Channel
Reapplix posted a video "3C Patch - Living cells in wound healing" on VIMEO
Oct 06, 2021
reapplix
Press Release: Reapplix : PRESS RELEASE: REAPPLIX RECEIVES CODING AND REIMBURSEMENT DETAILS FOR 3C PATCH® IN THE US - ALL OBSTACLES REMOVED FOR COMMERCIAL EXECUTION
Apr 25, 2021
Online PR Media
Press Release: Reapplix : Sustainable Us Reimbursement for Reapplix's 3C Patch
Oct 20, 2020
EIN Presswire
Press Release: Reapplix : REAPPLIX ANNOUNCES APPOINTMENT OF RICHARD TWOMEY TO BOARD OF DIRECTORS
Jul 15, 2020
Unquote
Reapplix: Novo Holdings et al. in $20m round for Reapplix | Unquote
Reapplix Competitors
1
2
3
4
5
6
7
8
9
10